Literature DB >> 22274960

Preservation of α-3 neuronal nicotinic acetylcholine receptor expression in sympathetic ganglia after brain death.

Nabor Bezerra de Moura Júnior1, João Carlos das-Neves-Pereira, José Ribas Milanez de Campos, Flávio Roberto Garbelini de Oliveira, Nelson Wolosker, Edwin Roger Parra, Vera Luiza Capelozzi, Fabio Biscegli Jatene.   

Abstract

The goal of this study was to evaluate if the immunohistochemical expression of alpha-3 neuronal nicotinic acetylcholine receptor subunit in sympathetic ganglia remains stable after brain death, determining the possible use of sympathetic thoracic ganglia from subjects after brain death as study group. The third left sympathetic ganglion was resected from patients divided in two groups: BD-organ donors after brain death and CON-patients submitted to sympathectomy for hyperhidrosis (control group). Immunohistochemical staining for alpha-3 neuronal nicotinic acetylcholine receptor subunit was performed; strong and weak expression areas were quantified in both groups. The BD group showed strong alpha-3 neuronal nicotinic acetylcholine receptor expression in 6.55% of the total area, whereas the CON group showed strong expression in 5.91% (p = 0.78). Weak expression was found in 6.47% of brain-dead subjects and in 7.23% of control subjects (p = 0.31). Brain death did not affect the results of the immunohistochemical analysis of sympathetic ganglia, and its use as study group is feasible.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22274960     DOI: 10.1007/s12035-012-8235-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  14 in total

Review 1.  Nicotinic acetylcholine receptors in autonomic ganglia.

Authors:  Vladimir I Skok
Journal:  Auton Neurosci       Date:  2002-04-18       Impact factor: 3.145

Review 2.  Sympathetic skin response: basic mechanisms and clinical applications.

Authors:  Robert Vetrugno; Rocco Liguori; Pietro Cortelli; Pasquale Montagna
Journal:  Clin Auton Res       Date:  2003-08       Impact factor: 4.435

3.  Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor.

Authors:  W Xu; S Gelber; A Orr-Urtreger; D Armstrong; R A Lewis; C N Ou; J Patrick; L Role; M De Biasi; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 4.  The diversity of neuronal nicotinic acetylcholine receptors.

Authors:  P B Sargent
Journal:  Annu Rev Neurosci       Date:  1993       Impact factor: 12.449

5.  An epidemiological study of hyperhidrosis.

Authors:  William Lear; Edward Kessler; Nowell Solish; Dee Anna Glaser
Journal:  Dermatol Surg       Date:  2007-01       Impact factor: 3.398

6.  Excitability recovery curve of the sympathetic skin response in healthy volunteers and patients with palmar hyperhidrosis.

Authors:  D Manca; J Valls-Solé; M A Callejas
Journal:  Clin Neurophysiol       Date:  2000-10       Impact factor: 3.708

7.  Is gender a predictive factor for satisfaction among patients undergoing sympathectomy to treat palmar hyperhidrosis?

Authors:  Nelson Wolosker; Marco Antonio Soares Munia; Paulo Kauffman; José Ribas Milanez de Campos; Guilherme Yazbek; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

Review 8.  Autonomic nervous system pharmacogenomics: a progress report.

Authors:  Shelli L Kirstein; Paul A Insel
Journal:  Pharmacol Rev       Date:  2004-03       Impact factor: 25.468

9.  Quality of life, before and after thoracic sympathectomy: report on 378 operated patients.

Authors:  José Ribas Milanez de Campos; Paulo Kauffman; Eduardo de Campos Werebe; Laert Oliveira Andrade Filho; Sergio Kusniek; Nelson Wolosker; Fábio Biscegli Jatene
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

10.  The history of the discovery of the vegatative (autonomic) nervous system.

Authors:  E H Ackerknecht
Journal:  Med Hist       Date:  1974-01       Impact factor: 1.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.